Thomas Henry Glocer's most recent trade in Merck & Co Inc was a trade of 615 Phantom Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 615 | 104,040 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 2,155 | 118,445 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 127.67 per share. | 01 Jun 2025 | 842 | 119,288 (0%) | 0% | 127.7 | 107,500 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 2,863 | 103,424 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 543 | 99,578 | - | - | Phantom Stock | |
| Morgan Stanley | Glocer Thomas Henry | Director | Grant, award, or other acquisition of securities at price $ 132.10 per share. | 01 Dec 2024 | 757 | 114,772 (0%) | 0% | 132.1 | 100,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 429 | 97,074 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 393 | 96,063 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 2,675 | 111,237 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 97.28 per share. | 01 Jun 2024 | 1,028 | 112,266 (0%) | 0% | 97.3 | 100,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 95,669 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 341 | 93,360 | - | - | Phantom Stock | |
| Merck & Company | Henry Glocer Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 412 | 92,419 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Glocer Henry | Director | Grant, award, or other acquisition of securities at price $ 80.26 per share. | 01 Dec 2023 | 1,246 | 106,670 (0%) | 0% | 80.3 | 100,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 437 | 91,370 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 389 | 90,340 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,167 | 102,156 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 82.10 per share. | 01 Jun 2023 | 1,218 | 103,374 (0%) | 0% | 82.1 | 100,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 89,950 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Sale of securities on an exchange or to another person at price $ 87.10 per share. | 03 May 2023 | 4,535 | 98,110 (0%) | 0% | 87.1 | 395,021 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 422 | 87,408 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 405 | 86,420 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 92.92 per share. | 01 Dec 2022 | 861 | 101,925 (0%) | 0% | 92.9 | 80,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 522 | 85,350 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 493 | 84,209 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,944 | 98,573 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 84.93 per share. | 01 Jun 2022 | 942 | 99,515 (0%) | 0% | 84.9 | 80,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 83,715 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 137 | 80,714 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 146 | 79,894 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 96.97 per share. | 01 Dec 2021 | 825 | 94,282 (0%) | 0% | 97.0 | 80,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 116 | 79,121 | - | - | Phantom Stock | |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 112 | 78,357 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,702 | 91,422 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 92.59 per share. | 01 Jun 2021 | 864 | 92,287 (0%) | 0% | 92.6 | 80,000 | Common Stock |
| Merck & Company | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 2,635 | 75,916 | - | - | Phantom Stock | |
| Morgan Stanley | Thomas Henry Glocer | Director | Grant, award, or other acquisition of securities at price $ 63.29 per share. | 01 Dec 2020 | 1,264 | 87,990 (0%) | 0% | 63.3 | 80,000 | Common Stock |